Sales & Marketing News | pharmaphorum

News

UK's Autumn Budget welcomed by pharma trade organisations

The life sciences industry in the UK has responded positively to measures introduced in the Autumn Budget detailed today by Chancellor Jeremy Hunt, including confirmation

News

Blow to Moderna as EU nixes mRNA vaccine patent

The European Patent Office has said it has invalidated a patent held by Moderna on mRNA-based COVID-19 vaccines, the latest development in an increasingly acrimonious disp

News

Abecma delay gives Carvykti a chance to catch up

Bristol-Myers Squibb and partner 2seventy bio are facing a delay in their attempt to bring BCMA-directed CAR-T therapy Abecma to the US market as an earlier-line therapy f

News

Generics group says VPAG may lead to shortages

Among those celebrating today’s agreement on a voluntary rebate scheme for branded medicines in the UK, there are dissenting voices, including a group representing manufac

News

EVERSANA taps Adobe Firefly in quest to ‘pharmatise’ GenAI

EVERSANA has taken another step forwards in its effort to put generative artificial intelligence (GenAI) at the heart of the pharma industry’s processes.

News

'Landmark' deal reached on UK voluntary rebate scheme

After months of wrangling, an agreement has finally been reached on a successor to the Voluntary Scheme for Branded Medicines Pricing and Access (VPAS), the system of reve

UK's Autumn Budget welcomed by pharma trade organisations

Blow to Moderna as EU nixes mRNA vaccine patent

Abecma delay gives Carvykti a chance to catch up

Generics group says VPAG may lead to shortages

EVERSANA taps Adobe Firefly in quest to ‘pharmatise’ GenAI

'Landmark' deal reached on UK voluntary rebate scheme

GSK to quit Stevenage for new R&D site in Cambridge

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks